Polymethoxylated flavones for treating insulin resistance

Details Polymethoxylated flavones for treating insulin resistance Polymethoxylated flavones for treating insulin resistance

A - Human Necessities

61

K

A61K 31/352 (2006.01) A61P 3/06 (2006.01) A61P 3/08 (2006.01)

Patent

CA 2445963

Compositions and methods for treating metabolic abnormalities arising from insulin resistance comprises the administration of tangeretin or a mixture of various polymethoxylated flavones (PMFs) are described. The PMFs are administered in various manners including orally. Supplementation with PMF to individuals affected by insulin resistance syndrome results in normalization of metabolic activity and improved glucose metabolism.

L'invention concerne des compositions et des procédés destinés à traiter des anomalies métaboliques dues à l'insulinorésistance. Ces procédés consistent à administrer de la tangérétine ou un mélange de différentes flavones méthoxylées (PMF). Ces PMF sont administrées de façons différentes incluant la voie orale. L'apport complémentaire de PMF à des individus affectés du syndrome d'insulinorésistance permet de normaliser l'activité métabolique et d'obtenir un meilleur métabolisme du glucose.

Affiliated with

Also associated with

Rating

Polymethoxylated flavones for treating insulin resistance does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Polymethoxylated flavones for treating insulin resistance, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymethoxylated flavones for treating insulin resistance will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1764083